Gelonghui, April 28 | Fuxiang Pharmaceutical (300497.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 340 million yuan, a year-on-year decrease of 14.45%; net profit attributable to shareholders of listed companies was 1.468,500 yuan, which turned a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 10.21 million yuan; basic earnings per share.
富祥药业(300497.SZ)：一季度净利润146.85万元 同比扭亏
Fuxiang Pharmaceutical (300497.SZ): Net profit of 1.468,500 yuan for the first quarter reversed the year-on-year loss
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.